![](https://www.rechargebiomedical.com/wp-content/uploads/2019/12/biasun.jpg)
Exosomes 21: Bias is unavoidable
The ability to be a reliable historian and judge of any changes after exosome therapy is a challenge for nearly everyone.
The ability to be a reliable historian and judge of any changes after exosome therapy is a challenge for nearly everyone.
This blog is about a case of seborrhoeic dermatitis that improved after exosomes given in conjuction with microneedling.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness